These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32445576)

  • 1. Drug-Coated Balloon Dilation Compared With Conventional Stenting Angioplasty for Intracranial Atherosclerotic Disease.
    Zhang J; Zhang X; Zhang J; Song Y; Zheng M; Sun L; Meng Y; Zhao W; Yin H; Wang W; Han J
    Neurosurgery; 2020 Oct; 87(5):992-998. PubMed ID: 32445576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of drug-coated balloon with conventional balloon for angioplasty in symptomatic intracranial atherosclerotic stenosis.
    Tang Y; Li T; Liu W; He Y; Zhu L; Wang ZL; He Y
    J Neurointerv Surg; 2023 Dec; 15(e3):e369-e374. PubMed ID: 36604174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of drug-coated balloons for intracranial atherosclerosis disease: a systematic review.
    Li G; Qiao H; Lin H; Wang R; Chen F; Li S; Yang W; Yin L; Cen X; Zhang Y; Cheng X; Wang AY
    Clin Neurol Neurosurg; 2022 Feb; 213():107065. PubMed ID: 34991058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
    J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
    [No Abstract]   [Full Text] [Related]  

  • 5. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Angioplasty without Stenting for Symptomatic, High-Grade Intracranial Stenosis with Poor Circulation.
    Wang Y; Ma Y; Gao P; Chen Y; Yang B; Jiao L
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1487-1492. PubMed ID: 29976834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of drug coated balloon angioplasty for intracranial atherosclerotic disease.
    Qiao H; Chang CH; Wang AY; Li S; Yang W; Li G; Cen X; Wang R; Lin H
    J Neurointerv Surg; 2023 Nov; 15(e2):e172-e177. PubMed ID: 36171100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leave Nothing Behind: Treatment of Intracranial Atherosclerotic Disease with Drug-Coated Balloon Angioplasty.
    Wang AY; Chang CH; Chen CC; Wu YM; Lin CM; Chen CT; Hsieh PC
    Clin Neuroradiol; 2021 Mar; 31(1):35-44. PubMed ID: 32720067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis.
    Ueda T; Takaishi S; Yoshie T; Usuki N; Tatsuno K; Ohtsubo H; Araga T; Kaga Y; Takada T
    BMC Neurol; 2022 Dec; 22(1):477. PubMed ID: 36510182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
    Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B
    Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.
    Fiorella D; Chow MM; Anderson M; Woo H; Rasmussen PA; Masaryk TJ
    Neurosurgery; 2007 Aug; 61(2):236-42; discussion 242-3. PubMed ID: 17762735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
    Cassese S; Wolf F; Ingwersen M; Kinstner CM; Fusaro M; Ndrepepa G; Ibrahim T; Ott I; Lammer J; Krankenberg H; Fusaro M
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e007055. PubMed ID: 30562083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque modification and stabilization after drug-coated balloon angioplasty for intracranial atherosclerotic lesions.
    Meng Y; Zhang Y; Chu X; Song Y; Zhao W; Zheng M; Zhang J; Han J
    Eur Radiol; 2023 Feb; 33(2):1112-1120. PubMed ID: 36136108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
    de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
    Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
    Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-Coated Balloon Treatment in Symptomatic Intracranial High Grade Stenosis : A Retrospective Study of 33 Patients.
    Remonda L; Diepers M; Berberat J; Kahles T; Anon J; Nedeltchev K; Gruber P
    Clin Neuroradiol; 2021 Mar; 31(1):45-49. PubMed ID: 32691077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provisional Stenting Using the Zilver PTX Drug-Eluting Stent After Drug-Coated Balloon Angioplasty: Initial Experience From the Double Drug Dose "3D" Study.
    Fanelli F; Cannavale A; Citone M; Santoni M; Gazzetti M; Falcone GM; Miele V
    J Endovasc Ther; 2020 Feb; 27(1):34-41. PubMed ID: 31637956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.